Senescence-associated reprogramming promotes cancer stemness
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Cellular senescence is a stress-responsive cell-cycle arrest program that terminates the further expansion of (pre-)malignant cells. Key signalling components of the senescence machinery, such as p16 INK4a, p21 CIP1 and p53, as well as trimethylation of lysine 9 at histone H3 (H3K9me3), also operate as critical regulators of stem-cell functions (which are collectively termed 'stemness'). In cancer cells, a gain of stemness may have profound implications for tumour aggressiveness and clinical outcome. Here we investigated whether chemotherapy-induced senescence could change stem-cell-related properties of malignant cells. Gene expression and functional analyses comparing senescent and non-senescent B-cell lymphomas from Eμ-Myc transgenic mice revealed substantial upregulation of an adult tissue stem-cell signature, activated Wnt signalling, and distinct stem-cell markers in senescence. Using genetically switchable models of senescence targeting H3K9me3 or p53 to mimic spontaneous escape from the arrested condition, we found that cells released from senescence re-entered the cell cycle with strongly enhanced and Wnt-dependent clonogenic growth potential compared to virtually identical populations that had been equally exposed to chemotherapy but had never been senescent. In vivo, these previously senescent cells presented with a much higher tumour initiation potential. Notably, the temporary enforcement of senescence in p53-regulatable models of acute lymphoblastic leukaemia and acute myeloid leukaemia was found to reprogram non-stem bulk leukaemia cells into self-renewing, leukaemia-initiating stem cells. Our data, which are further supported by consistent results in human cancer cell lines and primary samples of human haematological malignancies, reveal that senescence-associated stemness is an unexpected, cell-autonomous feature that exerts its detrimental, highly aggressive growth potential upon escape from cell-cycle blockade, and is enriched in relapse tumours. These findings have profound implications for cancer therapy, and provide new mechanistic insights into the plasticity of cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Persistent senescent cells are known to exert detrimental long-term effects on organ function and can promote tumorigenesis33,96,112,177,178.”
From COVID-19 and cellular senescence (2023) · cites this paper as [177]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the senescence programme is associated with enhanced stemness through cell- autonomous and cell- non- autonomous mechanisms”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Continuous transcriptional or, more generally, functional changes in senescent cells, and the permanent need to actively maintain senescencesupporting transcription puts the stability of cell cycle arrest at risk, occasionally leading to the restoration of proliferative properties with a potentially detrimental effect on tumour suppression 5,79 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Conversely, inactivation of Tp53 , the genes encoding either one of the three Rb family members or Suv39h1 in already senescent cells enables cell cycle re- entry out of the terminal arrest condition 5,125,126 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, retained senescence- associated gain of stemness in senescence escapers has been demonstrated in samples derived from patients with relapsed diffuse large B cell lymphoma that exhibited strong enrichment for WNT signalling activity reminiscent of senescence- associated stemness 5 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measured
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Rappsilber, J., Mann, M., & Ishihama, Y. (2007) · Nature Protocols · doi:10.1038/nprot.2007.261 · Cited by 4,641
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Regulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
Cited by
Items 301–400 of 1,000
Inflammatory signaling in genomically instable cancers
Talens, F., & van Vugt, M. A. T. M. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1638192 · Cited by 43
β-galactosidase responsive AIE fluorogene for identification and removal of senescent cancer cells
Gao, Z., Gao, H., Zheng, D., Xu, T., Chen, Y., Liang, C., Wang, L., Ding, D., & Yang, Z. (2020) · Science China Chemistry · doi:10.1007/s11426-019-9659-2 · Cited by 44
Wang, J., Yang, L., Dong, C., Wang, J., Xu, L., Qiu, Y., Weng, Q., Zhao, C., Xin, M., & Lu, Q. R. (2020) · Science Advances · doi:10.1126/sciadv.aaz6477 · Cited by 46
A natural product solution to aging and aging-associated diseases
Yang, C., Zhang, W., Dong, X., Fu, C., Yuan, J., Xu, M., Liang, Z. C., Qiu, C., & Xu, C. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107673 · Cited by 45
The role of vitamin D on redox regulation and cellular senescence
Sosa-Díaz, E., Cruz, E. Y. H., & Pedraza‐Chaverrí, J. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.10.003 · Cited by 44
Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer
Pardella, E., Pranzini, E., Nesi, I., Parri, M., Spatafora, P., Torre, E., Muccilli, A., Castiglione, F., Fambrini, M., Sorbi, F., et al. (2022) · Cells · doi:10.3390/cells11244026 · Cited by 43
Effects of senescence on the tumour microenvironment and response to therapy
Reynolds, L. E., Maallin, S., Haston, S., Martínez-Barberá, J. P., Hodivala‐Dilke, K., & Pedrosa, A. (2023) · FEBS Journal · doi:10.1111/febs.16984 · Cited by 45
Park, S. S., Lee, Y., Choi, Y. W., Lim, S. B., Park, S. H., Kim, H. K., Shin, J. S., Kim, Y. H., Lee, D. H., Kim, J., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113912 · Cited by 45
Emerging Roles of Vitamin B12 in Aging and Inflammation
Simonenko, S. Y., Bogdanova, D. A., & Kuldyushev, N. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25095044 · Cited by 45
Wang, Z., Li, K., Chen, W., Wang, X., Huang, Y., Wang, W., Wu, W., Cai, Z., & Huang, W. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03362-4 · Cited by 42
Sun, Y., Hu, H., Jing, X., Meng, Q., Yu, B., Cong, H., & Shen, Y. (2021) · Science China Materials · doi:10.1007/s40843-020-1627-4 · Cited by 43
Saleh, T., & Gewirtz, D. A. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01787-6 · Cited by 42
Morales-Valencia, J., Lau, L., Martí-Nin, T., Özerdem, U., & David, G. (2022) · Oncogene · doi:10.1038/s41388-022-02433-4 · Cited by 42
Benítez, S., Cordero, A., Santamaría, P. G., Redondo-Pedraza, J., Rocha, A. S., Collado-Solé, A., Jimenez, M., Sanz-Moreno, A., Yoldi, G., Santos, J. C., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.04.022 · Cited by 41
Insights from In Vivo Studies of Cellular Senescence
Prieto, L. I., Graves, S. I., & Baker, D. J. (2020) · Cells · doi:10.3390/cells9040954 · Cited by 41
Loison, I., Pioger, A., Paget, S., Metatla, I., Mariette, C., Piessen, G., Corfiotti, F., Eveno, C., Pruvot, F., Truant, S., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07131-5 · Cited by 41
GATA3 as a master regulator and therapeutic target in ovarian high‐grade serous carcinoma stem cells
Chen, H., Huang, R., Liew, P., Su, P., Chen, L., Weng, Y., Chang, C., Wang, Y., Chan, M. W. Y., & Lai, H. (2018) · International Journal of Cancer · doi:10.1002/ijc.31750 · Cited by 41
Residual Disease in Glioma Recurrence: A Dangerous Liaison with Senescence
Putavet, D. A., & de Keizer, P. L. J. (2021) · Cancers · doi:10.3390/cancers13071560 · Cited by 45
Cell-Intrinsic Mechanisms of Drug Tolerance to Systemic Therapies in Cancer
Léonce, C., Saintigny, P., & Ortiz‐Cuaran, S. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0038 · Cited by 44
Activatable senoprobes and senolytics: Novel strategies to detect and target senescent cells
Morsli, S., Doherty, G. J., & Muñoz-Espín, D. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111618 · Cited by 42
Cholangiokines: undervalued modulators in the hepatic microenvironment
Cai, X., Tacke, F., Guillot, A., & Liu, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1192840 · Cited by 40
A Novel ALDH1A1 Inhibitor Blocks Platinum-Induced Senescence and Stemness in Ovarian Cancer
Muralikrishnan, V., Fang, F., Given, T. C., Podicheti, R., Chtcherbinine, M., Metcalfe, T. X., Sriramkumar, S., O’Hagan, H. M., Hurley, T. D., & Nephew, K. P. (2022) · Cancers · doi:10.3390/cancers14143437 · Cited by 41
MDM2- an indispensable player in tumorigenesis
Zafar, A., Khan, M. J., & Naeem, A. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08512-3 · Cited by 41
Wang, P., Konja, D., Singh, S., Zhang, B., & Wang, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25041978 · Cited by 42
Progressive senescence programs induce intrinsic vulnerability to aging-related female breast cancer
Bai, H., Liu, X., Lin, M., Meng, Y., Tang, R., Guo, Y., Li, N., Clarke, M. F., & Cai, S. (2024) · Nature Communications · doi:10.1038/s41467-024-49106-2 · Cited by 42
Cui, J., Wang, Y., Dong, B., Qin, L., Wang, C., Zhou, P., Wang, X., Xu, H., Xue, W., Fang, Y., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31346 · Cited by 40
Schwarzenbach, C., Tatsch, L., Vilar, J. B., Rasenberger, B., Beltzig, L., Kaina, B., Tomicic, M. T., & Christmann, M. (2021) · Cancers · doi:10.3390/cancers13143585 · Cited by 42
Prognostic implications of cellular senescence in resected non-small cell lung cancer
Domen, A., Deben, C., Pauw, I. D., Hermans, C., Lambrechts, H. A. J., Verswyvel, J., Siozopoulou, V., Pauwels, P., Demaria, M., van de Wiel, M., et al. (2022) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-192 · Cited by 41
Zeng, C., Liu, Y., He, R. X., Lu, X., Dai, Y., Qi, G., Liu, J., Deng, J., Lu, W., Jin, J., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.935056 · Cited by 43
Senescence of Tumor Cells in Anticancer Therapy—Beneficial and Detrimental Effects
Piskorz, W. M., & Cechowska‐Pasko, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911082 · Cited by 43
Senescent cells enhance newt limb regeneration by promoting muscle dedifferentiation
Walters, H. E., Troyanovskiy, K. E., Graf, A. M., & Yun, M. H. (2023) · Aging Cell · doi:10.1111/acel.13826 · Cited by 39
Insights into the role of senescence in tumor dormancy: mechanisms and applications
DeLuca, V. J., & Saleh, T. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10082-6 · Cited by 40
Autophagy and senescence in cancer therapy
Patel, N. H., Bloukh, S., Alwohosh, E., Alhesa, A., Saleh, T., & Gewirtz, D. A. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.002 · Cited by 42
Saleh, T., Alhesa, A., Al-Balas, M., Abuelaish, O. M., Mansour, A. T., Awad, H., El‐Sadoni, M., Carpenter, V. J., & Azab, B. (2021) · Bioscience Reports · doi:10.1042/bsr20210079 · Cited by 40
Chen, J., Wang, Y., Zhang, W., Zhao, D., Zhang, L., Zhang, J., Fan, J., & Zhan, Q. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.472 · Cited by 40
Tumor dormancy: EMT beyond invasion and metastasis
Aouad, P., Quinn, H. M., Berger, A., & Brisken, C. (2023) · genesis · doi:10.1002/dvg.23552 · Cited by 40
Riviere-Cazaux, C., Carlstrom, L. P., Neth, B. J., Olson, I., Rajani, K. R., Rahman, M., Ikram, S., Mansour, M. A., Mukherjee, B., Warrington, A. E., et al. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00476-8 · Cited by 39
Zhang, M., Wang, Z., Zhang, Y., Guo, W., & Ji, H. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00068 · Cited by 39
Connecting cancer relapse with senescence
Pluquet, O., Abbadie, C., & Coqueret, O. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.08.004 · Cited by 39
From Development to Aging: The Path to Cellular Senescence
Sacco, A., Belloni, L., & Latella, L. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8071 · Cited by 41
Berghoff, A. S., Liao, Y., Karreman, M. A., Ilhan‐Mutlu, A., Gunkel, K., Sprick, M. R., Eisen, C., Keßler, T., Osswald, M., Wünsche, S., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0863 · Cited by 38
Self-citationSharma, M., Hunter, K. D., Fonseca, F. P., & Radhakrishnan, R. A. (2021) · Head & Neck · doi:10.1002/hed.26805 · Cited by 39
IER2-induced senescence drives melanoma invasion through osteopontin
Kyjacová, L., Saup, R., Rönsch, K., Wallbaum, S., Dukowic‐Schulze, S., Foss, A., Scherer, S. D., Rothley, M., Neeb, A., Grau, N., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02027-6 · Cited by 39
Bueschbell, B., Caniceiro, A. B., Suzano, P. M. S., Machuqueiro, M., Rosário-Ferreira, N., & Moreira, I. S. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100811 · Cited by 37
Senescence in cancer: Advances in detection and treatment modalities
Billimoria, R., & Bhatt, P. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115739 · Cited by 38
Beyer, M., Romanski, A., Mustafa, A. M., Pons, M., Büchler, I., Vogel, A., Pautz, A., Sellmer, A., Schneider, G., Bug, G., et al. (2019) · Cancers · doi:10.3390/cancers11101436 · Cited by 39
Sasaki, N., Gomi, F., Yoshimura, H., Yamamoto, M., Matsuda, Y., Michishita, M., Hatakeyama, H., Kawano, Y., Toyoda, M., Korc, M., et al. (2020) · Cancers · doi:10.3390/cancers12102976 · Cited by 37
Glutamine promotes escape from therapy-induced senescence in tumor cells
Pacifico, F., Badolati, N., Mellone, S., Stornaiuolo, M., Leonardi, A., & Crescenzi, E. (2021) · Aging · doi:10.18632/aging.203495 · Cited by 37
Hong, X., Wang, L., Zhang, K., Liu, J., & Liu, J. (2022) · Cells · doi:10.3390/cells11050877 · Cited by 38
Thome, C. D., Tausche, P., Hohenberger, K., Yang, Z., Krammer, S., Trufa, D. I., Sîrbu, H., Schmidt, J., & Finotto, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1328263 · Cited by 37
KLRG1 identifies regulatory T cells with mitochondrial alterations that accumulate with aging
Soto‐Heredero, G., Gabandé‐Rodríguez, E., Carrasco, E., Escrig-Larena, J. I., Heras, M. M. G. D. L., Delgado-Pulido, S., Francos-Quijorna, I., Blanco, E. M., Fernández-Almeida, Á., Abia, D., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00855-9 · Cited by 37
H3K9me3-mediated epigenetic regulation of senescence in mice predicts outcome of lymphoma patients
Schleich, K., Kase, J., Dörr, J. R., Trescher, S., Bhattacharya, A., Yu, Y., Wailes, E. M., Fan, D. N. Y., Lohneis, P., Milanovic, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17467-z · Cited by 32
Self-citationIdentification of the canonical and noncanonical role of miR-143/145 in estrogen-deficient bone loss
Xu, R., Shen, X., Xie, H., Zhang, H., Liu, D., Chen, X., Fu, Y., Zhang, P., Yang, Y. A., Cheng, J., et al. (2021) · Theranostics · doi:10.7150/thno.55041 · Cited by 38
Camberos, V., Baio, J., Mandujano, A., Martinez, A. F., Bailey, L. L., Hasaniya, N. W. M. A., & Kearns‐Jonker, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073577 · Cited by 36
Martell, E., Kuzmychova, H., Senthil, H., Kaul, E., Chokshi, C., Venugopal, C., Anderson, C. M., Singh, S. K., & Sharif, T. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01604-y · Cited by 35
Zhou, Z., Zhang, R., Zhang, Y., Xu, Y., Wang, R., Chen, S., Lv, Y., Chen, Y., Ren, Y., Luo, P., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217273 · Cited by 35
Sharma, N., Gnamlin, P., Durden, B. C., Gupta, V. K., Kesh, K., Garrido, V. T., Hadad, R., Dudeja, V., Saluja, A., & Banerjee, S. (2019) · Oncogenesis · doi:10.1038/s41389-019-0177-4 · Cited by 35
Cancer progression as a learning process
Shomar, A., Barak, O., & Brenner, N. (2022) · iScience · doi:10.1016/j.isci.2022.103924 · Cited by 40
Rentschler, M., Braumüller, H., Briquez, P. S., & Wieder, T. (2022) · Cancers · doi:10.3390/cancers14061364 · Cited by 38
Wang, S., Kim, J., Lee, C., Oh, D., Han, J., Kim, T., Kim, S. W., Seo, Y., Oh, S., & Jung, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119375 · Cited by 34
DNA methylation in senescence, aging and cancer
Xie, W., Baylin, S. B., & Easwaran, H. (2019) · Oncoscience · doi:10.18632/oncoscience.476 · Cited by 35
Chaturvedi, P., George, V., Shrestha, N., Wang, M., Dee, M. J., Zhu, X., Liu, B., Egan, J. O., D’Eramo, F., Spanoudis, C. M., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.025 · Cited by 35
Immunomodulatory effects of CDK4/6 inhibitors
Zhang, S., Xu, Q., Sun, W., Zhou, J., & Zhou, J. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188912 · Cited by 38
Jian, C., Wu, T., Wang, L., Gao, C., Fu, Z., Zhang, Q., & Shi, C. (2024) · Small · doi:10.1002/smll.202309279 · Cited by 33
Reprogramming cellular senescence and aging clocks for advanced cancer immunotherapy
Yang, H., Liu, D., Qiu, L., Wang, R., Zhang, C., Yu, D., Zhong, Q., Yuki, N., Song, Z., Zhu, Τ., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02459-8 · Cited by 38
Ki, M., Kim, D. H., Abdelhamid, M. A. A., & Pack, S. P. (2025) · Biosensors · doi:10.3390/bios15110737 · Cited by 35
Otani, Y., Sur, H. P., Rachaiah, G., Namagiri, S., Chowdhury, A. K., Lewis, C. T., Shimizu, T., Gangaplara, A., Wang, X., Vézina, A., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab014 · Cited by 35
Promises and challenges of senolytics in skin regeneration, pathology and ageing
Pils, V., Ring, N., Valdivieso, K., Lämmermann, I., Грубер, Ф., Schosserer, M., Grillari, J., & Ogrodnik, M. B. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111588 · Cited by 34
Sphingomyelin nanosystems decorated with TSP-1 derived peptide targeting senescent cells
Jatal, R., Saraiva, S. M., Vázquez‐Vázquez, C., Lelièvre, E., Coqueret, O., López‐López, R., & de la Fuente, M. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121618 · Cited by 33
Early Steps of Resistance to Targeted Therapies in Non-Small-Cell Lung Cancer
Delahaye, C., Figarol, S., Pradines, A., Favre, G., Mazières, J., & Calvayrac, O. (2022) · Cancers · doi:10.3390/cancers14112613 · Cited by 34
Cellular Senescence in Hepatocellular Carcinoma: The Passenger or the Driver?
Cai, X., Guillot, A., & Liu, H. (2022) · Cells · doi:10.3390/cells12010132 · Cited by 36
Anti-senescence therapies: a new concept to address cardiovascular disease
Stojanović, S. D., Thum, T., & Bauersachs, J. K. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf030 · Cited by 34
Jin, C., Li, Y., Su, Y., Guo, Z., Wang, X., Wang, S., Zhang, F., Zhang, Z., Shao, J., & Zheng, S. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03048-x · Cited by 33
Zhang, N., Ji, J., Zhou, D., Liu, X., Zhang, X., Liu, Y., Xiang, W., Wang, M., Zhang, L., Wang, G., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020849 · Cited by 33
EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis
Wang, K., Wang, Y., Wang, Y., Liu, S., Wang, C., Zhang, S., Zhang, T., & Yang, X. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02256-2 · Cited by 32
Tamai, M., Tatarano, S., Okamura, S., Fukumoto, W., Kawakami, I., Osako, Y., Sakaguchi, T., Sugita, S., Yonemori, M., Yamada, Y., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13192 · Cited by 36
Impact of Cancer Stem Cells on Therapy Resistance in Gastric Cancer
Otaegi-Ugartemendia, M., Matheu, A., & Carrasco‐García, E. (2022) · Cancers · doi:10.3390/cancers14061457 · Cited by 34
Harnessing redox signaling to overcome therapeutic-resistant cancer dormancy
Qin, S., Li, B., Ming, H., Nice, E. C., Zou, B., & Huang, C. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188749 · Cited by 32
Chojak, R., Fares, J., Petrosyan, E., & Lesniak, M. S. (2023) · Journal of Neuro-Oncology · doi:10.1007/s11060-023-04387-3 · Cited by 35
Lipid metabolism dynamics in cancer stem cells: potential targets for cancers
Du, J., & Qin, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1367981 · Cited by 33
Chrysophanol delays aging via insulin/IGF-1 signaling pathway
Zhang, H., Xiong, J., Wang, Q., Song, Q., Meng, L., Zhang, H., Bao, Y., Liu, F., & Xiao, Y. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.03.011 · Cited by 31
Admasu, T. D., & Yu, J. S. (2025) · Aging Cell · doi:10.1111/acel.70055 · Cited by 32
Dormancy in Breast Cancer, the Role of Autophagy, lncRNAs, miRNAs and Exosomes
Jahangiri, L., & Ishola, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095271 · Cited by 31
He, X., Liu, B., Peng, Y., Zhuo, R., & Cheng, S. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b17481 · Cited by 31
Nolan, J., Salvucci, M., Carberry, S., Barat, A., Segura, M. F., Fenn, J., Prehn, J. H. M., Stallings, R. L., & Piskareva, O. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.559553 · Cited by 32
Ao, K., Yin, M., Lyu, X., Xiao, Y., Chen, X., Zhong, S., Wen, X., Yuan, J., Ye, M., Zhang, J., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216658 · Cited by 31
Liu, S., Meng, Y., Zhang, Y., Qiu, L., Wan, X., Yang, X., Zhang, Y., Liu, X., Wen, L., Lei, X., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.04.007 · Cited by 33
Adoptive NK cell therapy: a potential revolutionary approach in longevity therapeutics
Deng, X., & Terunuma, H. (2024) · Immunity & Ageing · doi:10.1186/s12979-024-00451-2 · Cited by 36
Hu, H., Wang, Q., Yu, D., Tao, X., Guo, M., Tian, S., Zhang, Q., Xu, M., Geng, X., Zhang, H., et al. (2024) · Advanced Science · doi:10.1002/advs.202413122 · Cited by 40
Deregulated estrogen receptor signaling and DNA damage response in breast tumorigenesis
Rajan, A., Nadhan, R., Latha, N. R., Krishnan, N., Warrier, A. V., & Srinivas, P. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188482 · Cited by 33
Gadsden, N. J., Fulcher, C. D., Li, D., Shrivastava, N., Thomas, C., Segall, J. E., Prystowsky, M. B., Schlecht, N. F., Gavathiotis, E., & Ow, T. J. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0915 · Cited by 30
Kujundžić, R. N., Prpić, M., Đaković, N., Dabelić, N., Tomljanović, M., Mojzeš, A., Fröbe, A., & Gall‐Tros̆elj, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115681 · Cited by 30
Ezetimibe and Cancer: Is There a Connection?
Gu, J., Zhu, N., Li, H., Zhang, C., Gong, Y.-Z., Liao, D., & Li, Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.831657 · Cited by 30
Senescent Fibroblasts Generate a CAF Phenotype through the Stat3 Pathway
Li, H., Qiu, L., Liu, Q., Ma, Z., Xie, X., Luo, Y., & Wu, X. (2022) · Genes · doi:10.3390/genes13091579 · Cited by 30
Rising from the ashes: cellular senescence in regeneration
Walters, H., & Yun, M. H. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.06.002 · Cited by 32
Valenzuela, C. A., Quintanilla, R., Olate‐Briones, A., Venturini, W., Mancilla, D., Cayo, Á., Moore‐Carrasco, R., & Brown, N. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215292 · Cited by 30
Prime, S. S., Cirillo, N., Cheong, S. C., Prime, M. S., & Parkinson, E. K. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.05.025 · Cited by 31
Song, H., Wang, J., Wang, X., Yuan, B., Li, D., Hu, A., Guo, Y., Cai, S., Jin, S., Zhou, Y., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02271-4 · Cited by 29
Targeting chemoresistant senescent pancreatic cancer cells improves conventional treatment efficacy
Jaber, S., Warnier, M., Leers, C., Vernier, M., Goehrig, D., Médard, J., Vindrieux, D., Ziegler, D. V., & Bernard, D. (2023) · Molecular Biomedicine · doi:10.1186/s43556-023-00116-4 · Cited by 29
Mesenchymal Stem Cell Behavior under Microgravity: From Stress Response to a Premature Senescence
Pala, R., Cruciani, S., Manca, A., Garroni, G., Faqir, M. A. E., Lentini, V., Capobianco, G., Pantaleo, A., & Maioli, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097753 · Cited by 29
Metadata
- Authors
- Milanovic, M., Fan, D. N. Y., Belenki, D., Däbritz, J. H. M., Zhao, Z., Yu, Y., Dörr, J. R., Dimitrova, L., Lenze, D., Monteiro Barbosa, I. A., Mendoza-Parra, M. A., Kanashova, T., Metzner, M., Pardon, K., Reimann, M., Trumpp, A., Dörken, B., Zuber, J., Gronemeyer, H., Hummel, M., Dittmar, G., Lee, S., & Schmitt, C. A.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- German Cancer Research Center (DE)
- Memorial Sloan Kettering Cancer Center (US)
- Max Delbrück Center (DE)
- Centre National de la Recherche Scientifique (FR)
- Research Institute of Molecular Pathology (AT)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Corresponding author
- Schmitt, Clemens A.
- ORCID
- Venue
- Nature
- Published
- 2017-12-20
- Volume
- 553
- Issue
- 7686
- Pages
- 96-100
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2777786283
- Cited by
- 1,131
- References
- 60
- Citations by year
- 2026: 110 · 2025: 137 · 2024: 154 · 2023: 181 · 2022: 149 · 2021: 140 · 2020: 125 · 2019: 84 · 2018: 49 · 2017: 1
- FWCI
- 52.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cellular senescence, cancer stem cells, chemotherapy-induced senescence, senescence escape, Wnt signaling, H3K9me3, p53, p16INK4a, p21, B-cell lymphoma, acute lymphoblastic leukemia, acute myeloid leukemia, hematologic malignancies, clonogenic growth, self-renewal
- MeSH terms
- Animals, Clone Cells, Female, Humans, Male, Mice, Transgenic, Phenotype, Neoplastic Stem Cells, Biomarkers, Lymphoma, B-Cell, Cellular Senescence, Cell Line, Tumor, Cell Proliferation, Mice, Cell Cycle Checkpoints, Wnt Signaling Pathway, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.